Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Filter Content:
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Symposiums
Oncology
10
Mins
29th October 2024
ER+/HER2- Metastatic Breast Cancer – Treatment after ET + CDK4/6i
Over 70% of breast cancers are ER+/HER2-, for which the backbone of treatment is ET.1-3 Advanced breast cancer (aBC) can be considered to…
Oncology
8
Mins
29th October 2024
Patient-Centred Therapies for mNSCLC
The metastatic non-small cell lung cancer (mNSCLC) treatment landscape has vastly expanded over the past two decades as a result of…
Oncology
5
Mins
29th October 2024
Synergy of Tumour and Liquid Biopsy
The symposium took place during the 2024 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain, with the goal of…
Oncology
9
Mins
29th October 2024
Therapeutic Advances in Gastrointestinal Cancers: Immuno-oncology and Beyond
At the European Society for Medical Oncology (ESMO) Congress 2024 in Barcelona, Spain, the latest advancements in immunotherapy for…
Oncology
8
Mins
29th October 2024
Platinum Resistance in Ovarian Cancer
Approximately 80% of females with ovarian cancer are diagnosed with advanced disease (International Federation of Gynecology and…
Flagship Journal
10
Mins
24th October 2024
Advances in proteinuria-targeting therapy in IgAN
Advances in Therapy to Address Proteinuria in Patients with Immunoglobulin A Nephropathy. As the majority of patients with IgA…
Respiratory
10
Mins
22nd October 2024
Emerging Diagnostic and Therapeutic Concepts for Inflammation in Rare Lung Diseases
Bronchiectasis is a clinical condition defined as a chronic, abnormal dilation of the bronchi accompanied by classical symptoms…
Respiratory
10
Mins
22nd October 2024
Transforming Management of SEA
Asthma affects approximately 262 million people globally,1 with the number of asthma incidents having increased by around 15% over the…
Loading posts...
1
2
3
…
71
Next »